Načítá se...
Using Gene Editing to Establish a Safeguard System for Pluripotent Stem-Cell-Based Therapies
A major challenge in using human pluripotent stem cells (hPSCs) in therapy is the risk of teratoma formation due to contaminating undifferentiated stem cells. We used CRISPR-Cas9 for in-frame insertion of a suicide gene, iC9, into the endogenous SOX2 locus in human embryonic stem cell (ESC) line H1...
Uloženo v:
| Vydáno v: | iScience |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6909005/ https://ncbi.nlm.nih.gov/pubmed/31821946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2019.11.038 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|